Latest Financial Health News

Metgasco has pushed back the deadline for Vintage Energy's commitment to acquire its 25% stake in the Odin and Vali Gas Fields to 28 February 2026, with Vintage assuming additional cash call obligations as part of an interest-free loan arrangement.

Nutritional Growth Solutions reports improved cash flow and cost savings amid leadership changes, setting the stage for renewed growth in FY26.

Green360 Technologies has made significant strides in commercialising its low-carbon cement product Eco-Clay, delivering successful large-scale trials and securing a robust financial footing heading into 2026.

Beetaloo Energy Australia Limited reported a solid cash position of $17.96 million at the end of December 2025, supported by $6.8 million in unused financing facilities. The company’s liquidity covers approximately 2.6 quarters of current cash outflows, positioning it well as it awaits the activation of a new $30 million infrastructure facility.

Blue Energy Limited reports steady progress on its Sapphire gas project and awaits key government decisions on additional resource areas, positioning itself strongly in Queensland's evolving energy landscape.

Opthea Limited has streamlined its operations with a NASDAQ delisting and completed a strategic review, positioning itself to advance the OPT-302 treatment for LAM with a robust cash position.

The Calmer Co has posted a record $2.01 million in sales for Q2 FY26, propelled by a 9% increase in US revenue which now accounts for over half of the group’s total income. Strong retail and wholesale growth underpin the company’s expanding footprint in the natural relaxation market.

Beonic Limited has secured a $7.3 million contract phase for its Moroccan Airports project, completed a $4.27 million capital raise, and fully repaid a $4.65 million USD loan, underpinning its continued EBITDA profitability and positive cash flow.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

GreenX Metals has confirmed the validity of historical copper grades at its Tannenberg project in Germany through modern assays, while securing A$13.6 million in fresh capital to advance exploration. The company also won a key legal battle affirming its right to substantial compensation from Poland.

Forrestania Resources Limited has made significant strides in its expansion strategy during Q2 2025/2026, marked by the acquisition of Kula Gold Ltd, a substantial capital raise, and multiple project acquisitions across Western Australia.

Mustera Property Group reports strong sales momentum with $15.05 million contracted at its Verse on McCabe development, alongside a $3 million settlement at Forbes Residences, setting the stage for construction to begin in Q2 2026.